inhibitor therapies in myelofibrosis. Additional scientific studies in more substantial cohorts are important to respond to these queries.in combination with gemcitabine: inhibiting mobile proliferation; inhibiting tumor growth; increasing mobile apoptosis; no result when gemcitabine and extract are used individuallymutations are very prevalent in